TMCnet News

PixarBio CEO Frank Reynolds Named 2015 Irish Education 100 Recipient, a Listing of the Leading Irish-American Figures in Education Across the United States
[November 23, 2015]

PixarBio CEO Frank Reynolds Named 2015 Irish Education 100 Recipient, a Listing of the Leading Irish-American Figures in Education Across the United States


PixarBio Corporation is proud to announce that our Chief Executive Officer and Chief Science Officer Frank Reynolds was named to the 2015 Irish Education 100, a Listing of the Leading Irish-American Figures in Education Across the United States. The exclusive fall event and award ceremony will be held at the home of the Irish Consulate General in NYC--by special invitation only--on December 9, 2015.

The Irish Education 100 gives tribute to the enduring Irish success in education, especially at the university level. Across the nation, many top institutions have men and women of Irish blood in positions of leadership. The continuing success of Catholic education is a bedrock of American society.

"It's an honor to be recognized among the 40,000,000 Irish Americans whose ancestors came to America for an opportunity to survive and thrive. Frmal education provides the firm bedrock on which a productive life can be lived, and the Massachusetts Institute of Technology (MIT (News - Alert)) provided that foundation for me, as I set out to found new companies and invent new drugs and medical devices," said PixarBio CEO Frank Reynolds.



The Irish Education 100 honorees are some of the most distinguished and accomplished leaders in America with Irish heritage. It was first compiled by the Irish Voice newspaper in an effort to quantify the Irish commitment to excellence in education in the United States. This year's listing featuring the 2015 Irish Education 100 honorees will appear in a special edition issue of the Irish Voice on December 9.

About PixarBio Corporation


Cofounded by Frank Reynolds, MIT's Robert S. Langer, Katrin Holzhaus, and Dr. Jason Criscione, PixarBio is focused on researching and developing targeted delivery systems to treat pain, epilepsy, Parkinson's disease, and spinal cord injury. For more information visit www.pixarbio.com.


[ Back To TMCnet.com's Homepage ]